Niagen Bioscience Inc (NAGE) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Niagen Bioscience Inc (NAGE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $205.5M, listed on NASDAQ, employing roughly 117 people, carrying a beta of 2.02 to the broader market. Niagen Bioscience, Inc. Led by Robert N. Fried, public since 2015-06-24.
Snapshot as of Oct 13, 2026.
- Spot Price
- $2.58
- ATM IV
- 287.8%
- IV Rank
- 57.3%
- IV Percentile
- 99.2%
- Term Structure Slope
- -0.151
As of Oct 13, 2026, Niagen Bioscience Inc (NAGE) at-the-money implied volatility is 287.8%. IV rank is 57.3% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 99.2%. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
NAGE Strategy Selection at Current Volatility Levels
For Niagen Bioscience Inc options at 287.8% ATM IV, mid-range IV rank (57.3%) is the regime where directional conviction matters more than vol-regime positioning; strategy choice should follow the event calendar and the dealer-positioning view rather than IV rank alone. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
How to read the NAGE volatility surface
ATM IV currently prints at 287.8%, 57.3% IV rank, against 39.1% realized over the trailing 20 trading days. Implied is pricing above realized by 248.7 vol points, the typical variance-risk-premium positive state in which premium sellers earn the gap. The term-structure slope of -0.151 is inverted (backwardation) - near-dated IV trades above longer-dated, signaling acute near-term event risk.
NAGE IV rank and the variance risk premium
NAGE IV rank of 57.3% sits in the middle of its 1-year range - neither premium-selling nor premium-buying carries a structural edge from rank alone. Strategy choice should follow event calendar, dealer positioning, and the directional thesis. Compared with 60-day realized HV of 52.8%, current ATM IV is 235.0 vol points rich.
Trading vol on NAGE: practical notes
The variance risk premium - the persistent gap between implied and subsequently realized volatility - is positive on equity-market averages, which is why premium-selling carries a long-run edge. But the edge is averaged across a distribution; individual realizations can blow past the implied move in either direction. NAGE front-month expiration sits at 38 days; near-dated structures get the highest theta decay but also the largest gamma sensitivity, so the same vol-rank read translates into very different structures at 7 DTE vs 45 DTE. Pair the rank read with the dealer-gamma view, the term-structure shape, and the upcoming-event calendar to confirm the trade fits both the structural regime and the path-dependent risk. Risk-defined structures (credit/debit spreads, condors, butterflies) are usually safer than naked positions when the regime is uncertain.
NAGE volatility surface: linking strikes to tenors
Skew across strikes and the term structure across expirations together describe the NAGE implied-volatility surface - the two-dimensional grid of IV across strike and expiration that determines every option premium on the chain. Term structure tells you when the market expects the action; skew tells you which direction. Combined with the 57.3% IV rank, the surface gives a complete read on whether NAGE options are cheap, fair, or expensive across both dimensions. Practitioners watch surface dynamics (skew steepening, term-structure inversion) alongside level (IV rank) - level moves are common but surface shape changes typically signal regime-level shifts in how the chain is being positioned.
For NAGE specifically, the surface read fits into a broader options-trading toolkit. Single-leg directional positions (long calls or puts) depend almost entirely on level: cheap IV at any skew/term shape favors buyers, rich IV favors sellers. Risk-defined spreads (vertical credit/debit spreads, iron condors, butterflies) depend on both level and skew: put-skewed surfaces make put-side credit spreads collect more premium per width than call-side, and the asymmetry can compound or offset the directional thesis. Calendar and diagonal spreads depend on term shape: contango makes long-back-month / short-front-month structures cheaper to put on but harder to harvest theta from quickly. Pair the surface read with the dealer-gamma view, the upcoming-event calendar, and the underlying-trend context to choose the strike, the tenor, and the structure family that match both the regime and the conviction level.
Learn how volatility skew is reported and how to read the data →
Frequently asked NAGE volatility skew questions
- What is the current NAGE ATM implied volatility?
- As of Oct 13, 2026, Niagen Bioscience Inc (NAGE) at-the-money implied volatility is 287.8%. IV rank is 57.3% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is NAGE IV high or low historically?
- IV is near its 1-year median, a regime where strategy choice depends on directional conviction and event calendar rather than vol regime.
- What does NAGE volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.